Evaluation of (89)Zr-pertuzumab in Breast Cancer Xenografts

[Image: see text] Pertuzumab is a monoclonal antibody that binds to HER2 and is used in combination with another HER2–specific monoclonal antibody, trastuzumab, for the treatment of HER2+ metastatic breast cancer. Pertuzumab binds to an HER2 binding site distinct from that of trastuzumab, and its af...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquez, Bernadette V., Ikotun, Oluwatayo F., Zheleznyak, Alexander, Wright, Brian, Hari-Raj, Amrita, Pierce, Richard A., Lapi, Suzanne E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224522/
https://www.ncbi.nlm.nih.gov/pubmed/25058168
http://dx.doi.org/10.1021/mp500323d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224522/
https://www.ncbi.nlm.nih.gov/pubmed/25058168
http://dx.doi.org/10.1021/mp500323d

Ejemplares similares